We have previously linked families with autosomal-dominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8). By high-resolution recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2). It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains. Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies. These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathology, and progressive supranuclear palsy-like pathology. Clinical diagnoses of Parkinsonism with dementia or amyotrophy or both, with their associated pathologies, are also noted. Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders associated with parkinsonism.
Pubmed ID: 15541309 RIS Download
Mesh terms: Adult | Amino Acid Sequence | Blotting, Northern | Brain | Chromosome Mapping | Female | Genetic Linkage | Humans | Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | Lewy Bodies | Male | Middle Aged | Molecular Sequence Data | Mutation | Nerve Degeneration | Parkinsonian Disorders | Pedigree | Protein Kinases | Protein-Serine-Threonine Kinases | Proteins | Reverse Transcriptase Polymerase Chain Reaction
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.